Have a personal or library account? Click to login
MUC1 immunotherapy against a metastatic mammary adenocarcinoma model: Importance of IFN-gamma Cover

MUC1 immunotherapy against a metastatic mammary adenocarcinoma model: Importance of IFN-gamma

PRILOZI
Volume 37 (2016): Issue 1 (June 2016)
By: Catherine J. Lees,  Nechama Smorodinsky,  Galit Horn,  Daniel H. Wreschner,  Ian F.C. McKenzie,  Geoffrey Pietersz,  Lily Stojanovska and  Vasso Apostolopoulos  
Open Access
|Jul 2016

Authors

Catherine J. Lees

Nechama Smorodinsky

Galit Horn

Daniel H. Wreschner

Ian F.C. McKenzie

Geoffrey Pietersz

Lily Stojanovska

Vasso Apostolopoulos

vasso.apostolopoulos@vu.edu.au

DOI: https://doi.org/10.1515/prilozi-2016-0001 | Journal eISSN: 1857-8985 | Journal ISSN: 1857-9345
Journal RSS Feed
Language: English
Page range: 15 - 25
Published on: Jul 15, 2016
Published by: Macedonian Academy of Sciences and Arts
In partnership with: Paradigm Publishing Services
Publication frequency: 2 issues per year
Keywords:
MUC1. MHC class I,
interferon-gamma,
tumour,
immunotherapy
Related subjects:
Medicine,
Basic medical science,
History and ethics of medicine,
Clinical medicine,
Clinical medicine, other,
Social sciences,
Education,
Education, other

© 2016 Catherine J. Lees, Nechama Smorodinsky, Galit Horn, Daniel H. Wreschner, Ian F.C. McKenzie, Geoffrey Pietersz, Lily Stojanovska, Vasso Apostolopoulos, published by Macedonian Academy of Sciences and Arts
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Previous articleVolume 37 (2016): Issue 1 (June 2016)Next article